Tag: Harm reduction | Page 11

Health Canada’s statement on the status of naloxone is a welcome drug policy paradigm shift

March 4, 2016 • By Dr. Lynne Leonard

The administration of naloxone, a chemical compound that effectively temporarily reverses the effects of an opioid overdose, is recommended by the World Health Organization to be used in the case of an opioid overdose. Naloxone is currently available in Canada only in an injectable form and by prescription only; it can only be administered to the person named on the prescription, not to a third party.

Canada’s anti-harm reduction guardians close door on hepatitis strategy

October 13, 2015 • By Laurie Edmiston and Melisa Dickie

We just returned from the first World Hepatitis Summit hosted by the World Hepatitis Alliance (WHA) in partnership with the World Health Organization (WHO) and the Scottish government. The Scottish government was a partner because Scotland has exercised leadership in the fight against hepatitis C and, unlike Canada, has a national strategy to combat hepatitis C.* The focus of the World Hepatitis Summit was viral hepatitis, specifically hepatitis B and C. Hepatitis B has a vaccine; giving it to newborns or school-age children in Canada is standard practice. However, this is not the case in much of the developing...

What Canada can learn from Australia’s HIV response

October 21, 2014 • By Laurie Edmiston

While at AIDS 2014, CATIE’s Ed Jackson and I met with a number of Australian agencies to pursue a plan to share best practices around gay men’s sexual health programming. I was already familiar with some of Australia’s powerful awareness, prevention and testing campaigns, but a closer look at the Aussie HIV response has been eye-opening and provides many useful learnings for Canada.